Detalhe da pesquisa
1.
Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients.
Br J Dermatol
; 190(2): 258-265, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792727
2.
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.
Lancet
; 389(10083): 2031-2040, 2017 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28342637
3.
Efficacy and safety of dupilumab in bullous pemphigoid: a retrospective multicentric study of 36 patients.
Br J Dermatol
; 189(2): 244-246, 2023 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37155583
4.
Belimumab for refractory manifestations of cutaneous lupus: A multicenter, retrospective observational study of 16 patients.
J Am Acad Dermatol
; 83(6): 1816-1819, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32439463
5.
New insights in COVID-19-associated chilblains: A comparative study with chilblain lupus erythematosus.
J Am Acad Dermatol
; 83(4): 1219-1222, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32622895
6.
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.
JAMA Dermatol
; 160(3): 290-296, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38265821
7.
Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial.
JAMA Dermatol
; 156(5): 545-552, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32186656
8.
Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population.
J Invest Dermatol
; 139(4): 835-841, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30543900
9.
Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.
J Invest Dermatol
; 139(1): 31-37, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30301637
10.
Successful ustekinumab treatment in a patient with psoriasis and subacute cutaneous lupus erythematosus.
Int J Dermatol
; 59(4): e118-e120, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31957866
11.
Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.
J Invest Dermatol
; 131(3): 637-43, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20944650
12.
Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study.
Arch Dermatol
; 145(5): 537-42, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19451497
13.
Pemphigus in elderly adults: clinical presentation, treatment, and prognosis.
J Am Geriatr Soc
; 60(6): 1185-7, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22690997